IntelGenx Technologies Corp. (OTCQB: IGXT)
Market Cap: $53,024,590
Outstanding Shares: 64,672,021
Analysis: IntelGenx Technologies Corp (OTCQB: IGXT) has seen a consistent growth in revenue since 1Q16. The company’s most recent press release indicates potential for market share in a $4 billion CNS (“Central Nervous System) market.
IntelGenx Corp., (TSX VENTURE:IGX) (IGXT), today announced the signing of a definitive agreement with Chemo Group (“Chemo”) for the co-development and commercialization of a generic tablet in the area of CNS (central nervous system) on a worldwide basis. Continue Reading
UPTICK Newswire LLC is not an investment advisor. Investors are strongly encouraged to do their own due diligence and review all company documents and press releases to ensure the company noted above fits their own investment qualifications.
Source: Uptick Newswire